TimeScale Financial’s Ginkgo Bioworks DNA Stock Holding History

TimeScale Financial’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.61K	Hold	48	–	–	﹤0.01%	468
2023 Q1	$2.58K	Hold	48	–	–	﹤0.01%	473
2022 Q4	$6.05K	Hold	48	–	–	﹤0.01%	362
2022 Q3	$6K	Hold	48	–	–	﹤0.01%	359
2022 Q2	$5K	Hold	48	–	–	﹤0.01%	356
2022 Q1	$8K	Hold	48	–	–	﹤0.01%	328
2021 Q4	$16K	Hold	48	–	–	﹤0.01%	250
2021 Q3	$22K	Buy	+48	New	+$23.4K	0.01%	236

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

TimeScale Financial's DNA Position: Q2 2023 in Review

TimeScale Financial held its Ginkgo Bioworks (DNA) position steady in Q2 2023 at 48 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

TimeScale Financial first reported a position in DNA in Q3 2021 and has held it in 8 quarters since. The position peaked at $22K in Q3 2021. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

TimeScale Financial held 48 shares of Ginkgo Bioworks worth $3.61K as of Q2 2023.
TimeScale Financial left its Ginkgo Bioworks share count unchanged in Q2 2023.
Ginkgo Bioworks made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #468 holding.
TimeScale Financial first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 8 quarters since.
TimeScale Financial's Ginkgo Bioworks position peaked at $22K in Q3 2021.
315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.